This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Disorders of muscle in diseases classified elsewhere
M13_MUSCLEINOTH
muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
46 |
4. Check minimum number of eventsNone |
46 |
5. Include endpointsNone |
46 |
6. Filter based on genotype QC (FinnGen only) |
46 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M60-M63
- Name in latin
- Morbositates musculorum in morbis alibi classificatis
Similar endpoints
↥List of similar endpoints to
Disorders of muscle in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Disorders of muscles
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 333 | 191 | 142 |
| Only index persons | 304 | 183 | 121 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | - | 47.83 | 39.78 |
| Only index persons | 44.87 | 47.58 | 40.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 46 | 32 | 14 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 54.36 | 47.13 | 70.88 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
0
+∞
7.48
6.7
0.0
u/ml
6170.0
—
—
7
0
(3013512) EKG study
21
106
2.81
2.85
4.4
4.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
6
9.14
2.82
1.2
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
6
9.14
2.82
1.2
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
10
6.70
2.79
1.7
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
10
6.70
2.79
1.5
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
29
183
2.58
2.42
6.2
3.6
estimate
0.0
0.0
—
5
41
(3035350) Ketones [Presence] in Urine by Test strip
29
183
2.58
2.42
6.2
3.6
estimate
0.0
0.0
—
5
43
(42870588) Differential panel, method unspecified - Blood
22
122
2.54
2.40
10.9
4.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
23
3.98
2.40
1.5
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
29
184
2.56
2.38
12.2
5.5
e9/l
0.0
0.0
0.62
24
166
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
13
5.13
2.35
8.3
1.8
mg/l
3.3
3.7
—
6
8
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
9
6.07
2.27
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
14
4.75
2.23
4.2
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
32
3.24
2.14
1.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
28
183
2.35
2.04
8.5
4.7
estimate
0.0
0.0
—
5
43
(3037522) Nuclear Ab [Titer] in Serum
11
46
2.83
2.03
1.8
1.4
titre
336.0
283.3
—
5
12
(3026782) Osmolality of Urine
16
82
2.46
2.00
7.6
3.0
mosm/kgh2o
629.1
528.6
1.15
16
73
(3021447) Carbon dioxide [Partial pressure] in Venous blood
9
34
3.04
1.99
4.0
4.4
kpa
5.7
5.8
—
9
34
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
17
91
2.38
1.93
2.2
1.8
mg/l
4.1
3.4
0.34
12
81
(3012544) pH of Venous blood
9
35
2.94
1.93
4.0
4.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
12
55
2.60
1.87
3.4
2.6
e6/l
2.4
2.7
—
7
27
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
5
13
4.17
1.76
2.6
2.2
ug/l
187.2
239.5
—
5
13
(3024354) Oxygen [Partial pressure] in Venous blood
8
31
2.90
1.75
4.0
3.2
kpa
4.5
4.3
—
8
31
(3003694) ABO and Rh group [Type] in Blood
19
111
2.21
1.74
1.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
10
43
2.69
1.74
1.6
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
26
173
2.16
1.72
3.8
3.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
14
3.87
1.66
2.6
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
20
3.29
1.64
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
20
3.29
1.64
1.7
13.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
21
3.13
1.56
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
78
2.14
1.40
2.8
3.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
18
2.98
1.32
5.2
5.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
18
113
1.97
1.32
5.2
2.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
18
116
1.91
1.21
3.9
3.5
mg/mmol
13.2
9.3
0.12
11
73
(3023368) Bacteria identified in Blood by Culture
16
99
1.94
1.20
7.9
3.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
20
2.68
1.18
8.6
4.4
—
—
—
0
0
(3019225) pH of Specimen
7
31
2.48
1.16
4.4
5.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
21
2.54
1.12
3.4
7.7
mmol/l
25.5
25.7
—
5
21
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
11
61
2.06
1.10
3.3
2.3
e6/l
0.4
1.9
—
6
33
(3041096) Erythrocytes [Presence] in Urine by Automated
17
111
1.84
1.08
7.3
3.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
112
1.82
1.04
12.9
6.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
9
50
1.99
1.04
6.0
5.9
mmol/l
1.2
1.1
—
9
45
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
20
140
1.76
1.00
7.6
4.7
ng/l
45.8
32.7
0.22
14
94
(3000850) Epithelial cells [#/volume] in Urine
14
88
1.85
0.99
6.4
2.4
e6/l
11.0
4.0
0.64
14
77
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
6
28
2.31
0.95
6.2
2.0
ng/l
646.8
156.0
—
6
23
(3044640) Blood type and Crossmatch panel - Blood
18
124
1.74
0.94
2.5
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
8
45
1.94
0.90
3.1
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
13
83
1.79
0.86
3.5
6.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
16
109
1.72
0.86
6.8
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
19
136
1.68
0.86
6.9
2.8
—
—
—
0
0
(4010399)
6
32
2.00
0.85
1.8
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
59
1.89
0.84
4.6
2.4
—
—
—
0
0
(3000492) Spirometry study
6
33
1.94
0.82
2.7
2.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
27
216
1.61
0.76
5.2
4.8
mmol/l
8.2
6.8
1.53
27
201
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
40
1.88
0.75
2.1
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
20
150
1.59
0.73
7.3
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
22
169
1.58
0.73
2.7
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
21
160
1.57
0.72
5.6
4.4
g/l
35.0
36.0
0.35
21
155
(3037467) Urinalysis macro (dipstick) panel - Urine
32
269
1.62
0.72
7.2
3.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
16
115
1.60
0.69
3.4
2.7
mmol/l
6.8
7.6
0.30
11
96
(3012516) Albumin [Mass/volume] in Urine
15
107
1.60
0.66
3.5
3.0
mg/l
93.1
77.4
—
10
67
(3016502) Oxygen saturation in Arterial blood
5
30
1.75
0.63
2.6
8.8
%
96.7
95.7
—
5
30
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
38
1.66
0.57
2.3
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
39
1.62
0.55
6.2
4.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
7
47
1.58
0.50
5.4
4.8
%
35.4
37.0
—
7
28
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
88
1.49
0.46
2.2
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
33
1.58
0.43
7.0
3.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
16
0.00
0.42
0.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
30
267
1.36
0.36
5.2
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
6
45
1.38
0.35
21.0
17.6
—
1.3
—
0
10
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
26
228
1.32
0.34
3.0
3.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
7
55
1.32
0.32
1.4
2.1
s
31.2
29.7
—
7
55
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
61
1.38
0.30
2.8
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
17
143
1.30
0.29
15.8
10.5
inr
1.5
1.3
—
6
55
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
40
380
1.40
0.27
25.3
13.6
mg/l
21.9
25.1
0.32
33
289
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
39
1.32
0.24
6.6
7.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.6
—
21.2
—
0
13
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
6
50
1.23
0.21
1.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
12
134
0.86
0.10
2.7
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
74
1.10
0.08
2.0
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
10
99
1.01
0.00
4.7
5.3
ug/l
82.1
2.1
—
10
90
(3009542) Hematocrit [Volume Fraction] of Blood
35
355
0.94
0.00
23.9
13.7
%
38.1
39.3
0.24
23
253
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
7.6
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
40
397
1.06
0.00
26.9
15.6
umol/l
84.1
77.7
0.23
40
397
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
63
0.95
0.00
1.2
1.8
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
5
0.00
0.00
0.0
1.2
—
14.4
—
0
5
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(44806118)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(44790048)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
73
0.95
0.00
1.1
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
13.6
—
0
6
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
6.1
—
0
5
(4268621)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(44790047)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
11.1
—
0
5
(4094501)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
7
0.00
0.00
0.0
1.1
—
135.3
—
0
7
(3016879) Cocaine [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
3.7
—
1.7
—
0
6
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
87.2
—
0
5
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.7
—
49.2
—
0
6
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.4
—
203.1
—
0
5
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44790049)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
2.0
—
34.4
—
0
5
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
3.0
—
92.2
—
0
6
(3040151) Glucose [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
4.2
—
5.5
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint M13_MUSCLEINOTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_MUSCLEINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_MUSCLEINOTH – Disorders of muscle in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data